Pilot Study of Bone Biopsy and Aspirate in Women With Metastatic Breast Cancer
Metastatic Breast Cancer
Conditions: official terms
Breast Neoplasms
Study Type
Study Phase
Study Design
Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Basic Science
Name: Bone marrow aspirates and biopsy
Type: Procedure
Overall Status
This is a feasibility study to demonstrate the team's ability to collect bone marrow aspirates and biopsies for research purposes from women with metastatic breast cancer.
Criteria for eligibility
Healthy Volunteers: No
Maximum Age: N/A
Minimum Age: 21 Years
Gender: Both
Criteria: Inclusion Criteria:

- Patients with metastatic breast cancer (any site) age 21 or older

- Patients willing and able to provide informed consent & perform study procedures

- Patients may enroll with stable, responding or progressive tumor burden

- Performance status of 0,1 or 2

Exclusion Criteria:

- Patients unable or unwilling to provide informed consent and or perform study procedures

- Patients with active, uncontrolled coagulopathy

- Patients on treatment dose anticoagulation or an International Normalised Ratio of 2 or greater if on warfarin

- Patients who are known to be pregnant are not eligible to participate in this study during the time of the pregnancy
University of Michigan
Ann Arbor, Michigan, United States
Status: Recruiting
Contact: Catherine H Van Poznak, MD - cvanpoz@umich.edu
Start Date
August 2013
Completion Date
August 2016
University of Michigan Cancer Center
University of Michigan Cancer Center
Record processing date
ClinicalTrials.gov processed this data on July 28, 2015
ClinicalTrials.gov page